Use of certain phenyl naphthyl compounds that have no significant affinity for alpha or beta er for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis

摘要

USE OF CERTAIN FENIL-NAPHYTLE COMPOUNDS WHICH HAVE NO SIGNIFICANT AFFINITY FOR ER ALPHA OR BETA FOR THE PROTECTION OF NEURANS AND OLIGODENDRACITS IN THE TREATMENT OF MULTIPLE SCLEROSIS. The present invention relates to a novel use for certain similar pheninaphthyl compounds - SERMs that do not exhibit alpha or beta type estrogen receptor (ER) affinity in the treatment of multiple sclerosis.